Although other studies have suggested that activation of the MEK/ERK pathway may have a negative impact on erythroid differentiation [30], [31], our data suggest that active MEK expression in HSCs does not directly suppress red blood cell production since mice do not develop anemia until later time points (Figure 3C). The gene discussed is MAP2K7; the disease is anemia.